This is the first 64-wire cobalt chromium flow diverter in the U.S. designed to re-direct blood flow and promote aneurysm healing. Surpass Evolve is Stryker's latest innovation in flow diversion and follows the launch of Surpass Streamline in late 2018.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
